Evidence for risk of cardiomyopathy with hydroxychloroquine

Lupus. 2012 Dec;21(14):1594-6. doi: 10.1177/0961203312462757. Epub 2012 Oct 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy
  • Cardiomyopathies / chemically induced*
  • Cardiomyopathies / epidemiology
  • Dose-Response Relationship, Drug
  • Humans
  • Hydroxychloroquine / administration & dosage
  • Hydroxychloroquine / adverse effects*
  • Hydroxychloroquine / therapeutic use
  • Lupus Erythematosus, Systemic / drug therapy
  • Middle Aged
  • Risk
  • Time Factors

Substances

  • Antirheumatic Agents
  • Hydroxychloroquine